Universal Technical Institute Inc’s filing revealed that its Director Coliseum Capital Management, L acquired Company’s shares for reported $8.81 million on Dec 03 ’25. In the deal valued at $24.81 per share,355,236 shares were bought. As a result of this transaction, Coliseum Capital Management, L now holds 3,779,610 shares worth roughly $104.54 million.
Then, Coliseum Capital Management, L bought 191,830 shares, generating $4,868,645 in total proceeds. Upon buying the shares at $25.38, the Director now owns 3,971,440 shares.
Before that, Coliseum Capital Management, L bought 467,020 shares. Universal Technical Institute Inc shares valued at $11,395,288 were divested by the Director at a price of $24.40 per share. As a result of the transaction, Coliseum Capital Management, L now holds 3,424,374 shares, worth roughly $94.72 million.
A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Northland Capital began covering UTI with “an Outperform” recommendation on January 10, 2024. Argus revised its rating on June 23, 2023. It rated UTI as “a Hold” which previously was an “a Buy”.
Price Performance Review of UTI
On Monday, Universal Technical Institute Inc [NYSE:UTI] saw its stock jump 0.58% to $27.66. Over the last five days, the stock has gained 0.80%. Universal Technical Institute Inc shares have risen nearly 9.50% since the year began. Nevertheless, the stocks have risen 5.86% over the past one year.
How much short interest is there in Universal Technical Institute Inc?
A steep rise in short interest was recorded in Universal Technical Institute Inc stocks on 2025-12-31, growing by 0.64 million shares to a total of 2.78 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 2.13 million shares. There was a rise of 23.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 12, 2022 when Rosenblatt began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
